La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Target Healthcare REIT Gestion

Gestion contrôle des critères 1/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Kenneth MacKenzie

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDG	n/a
Durée du mandat du directeur général	no data
Propriété du PDG	n/a
Durée moyenne d'occupation des postes de direction	14.7yrs
Durée moyenne du mandat des membres du conseil d'administration	2.6yrs

Mises à jour récentes de la gestion

Recent updates

Target Healthcare REIT PLC Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 16

What Type Of Shareholders Own The Most Number of Target Healthcare REIT PLC (LON:THRL) Shares?

Mar 16

Target Healthcare REIT PLC (LON:THRL) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Jan 22

PDG

Kenneth MacKenzie (74 yo)

no data

Titularisation

Mr. Kenneth Macangus MacKenzie, MA, CA serves as Founder & Chief Executive of Target Fund Managers Limited, the Investment Manager of Target Healthcare REIT plc. Mr. MacKenzie founded the Target Advisers L...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Kenneth MacKenzie	Founder & Chief Executive of Target Fund Managers Limited	no data	pas de données	pas de données
Gordon Bland	Finance Director of Target Fund Managers Limited	no data	pas de données	pas de données
John Flannelly	Head of Investment - Target Fund Managers Limited	14.7yrs	pas de données	pas de données
Andrew Brown	Head of Healthcare - Target Fund Managers Limited	14.7yrs	pas de données	pas de données
Scott Steven	Head of Asset Management - Target Fund Managers Limited	6.7yrs	pas de données	pas de données
Donald Cameron	Company Secretary & Director of Financial Reporting - Target Fund Managers Limited	no data	pas de données	pas de données

14.7yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de THRL est chevronnée et expérimentée (ancienneté moyenne 14.6 ans).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Richard Cotton	Senior Independent Director	1.8yrs	UK£26.00k	0.0048% £ 25.0k
Michael Brodtman	Independent Non-Executive Director	1.7yrs	UK£19.50k	0.0039% £ 20.2k
James Niblett	Independent Non-Executive Director	3.1yrs	UK£45.50k	0.0039% £ 20.1k
Alison Fyfe	Independent Chairman of the Board	4.3yrs	UK£47.60k	0.0016% £ 8.3k
Amanda Thompsell	Independent Non-Executive Director	2.6yrs	UK£39.00k	pas de données

2.6yrs

Durée moyenne de l'emploi

65yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de THRL ne sont pas considérés comme expérimentés (ancienneté moyenne 2.5 ans), ce qui suggère un nouveau conseil d'administration.

Target Healthcare REIT Gestion

Gestion contrôle des critères 1/4

Informations clés

Mises à jour récentes de la gestion

High number of new and inexperienced directors

High number of new and inexperienced directors

Target Healthcare REIT PLC Appoints Michael Brodtman as an Independent Non-Executive Director, Effective 1 January 2023

Target Healthcare REIT PLC, Annual General Meeting, Dec 06, 2022

Target Healthcare REIT plc Announces Board Changes

Target Healthcare REIT PLC Announces Appointment of Amanda Thompsell as an Independent Non-Executive Director

Recent updates

Dividend of UK£0.014 announced

Target Healthcare REIT PLC Declares Fourth Interim Dividend for the Period from 1 April 2024 to 30 June, Payable on 30 August 2024

Now 19% overvalued

An undisclosed buyer acquired Four UK care homes from Target Healthcare REIT PLC (LSE:THRL) for £44.5 million.

Now 22% overvalued

Now 22% overvalued

Now 20% overvalued after recent price rise

Now 20% overvalued after recent price rise

Dividend of UK£0.014 announced

Target Healthcare REIT PLC Declares Third Interim Dividend for the Period from 1 January 2024 to 31 March 2024, Payable on 31 May 2024

First half 2024 earnings released: EPS: UK£0.05 (vs UK£0.055 loss in 1H 2023)

Target Healthcare REIT PLC to Report First Half, 2024 Results on Mar 12, 2024

Fourth quarter dividend of UK£0.014 announced

Target Healthcare Reit plc Declares Second Interim Dividend for the Period from 1 October 2023 to 31 December 2023, Payable on 23 February 2024

Now 20% undervalued

Now 20% undervalued

Now 21% undervalued

Now 20% undervalued

Target Healthcare REIT PLC Declares First Interim Dividend for the Period from 1 July 2023 to 30 September 2023, Payable on 24 November 2023

Full year 2023 earnings: EPS misses analyst expectations

Target Healthcare REIT PLC to Report Fiscal Year 2023 Results on Oct 10, 2023

Target Healthcare REIT PLC Declares Fourth Interim Dividend for the Year Ended 30 June 2023, Payable on August 25, 2023

Target Healthcare REIT PLC Declares Third Interim Dividend for the Year Ending 30 June 2023, Payable on 26 May 2023

First half 2023 earnings released: UK£0.055 loss per share (vs UK£0.032 profit in 1H 2022)

Now 21% undervalued after recent price drop

Target Healthcare REIT PLC Announces Second Interim Dividend for the Year Ending 30 June 2023, Payable on 24 February 2023

High number of new and inexperienced directors

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

High number of new and inexperienced directors

Target Healthcare REIT PLC Appoints Michael Brodtman as an Independent Non-Executive Director, Effective 1 January 2023

Target Healthcare REIT PLC, Annual General Meeting, Dec 06, 2022

Now 21% undervalued after recent price drop

Price target decreased to UK£0.97

Target Healthcare REIT PLC Announces First Interim Dividend for the Period ended September 30, 2022, Payable on 25 November 2022

Price target decreased to UK£0.97

Consensus forecasts updated

Target Healthcare REIT PLC Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Target Healthcare REIT plc Announces Board Changes

Price target decreased to UK£1.09

Price target decreased to UK£1.21

Target Healthcare REIT PLC Declares Fourth Interim Dividend for the Year Ended 30 June 2022, Payable on August 26, 2022

Target Healthcare REIT PLC Declares Third Interim Dividend for the Year Ending 30 June 2022, payable on 27 May 2022

Consensus EPS estimates fall by 17%

First half 2022 earnings: EPS exceeds analyst expectations

Upcoming dividend of UK£0.017 per share

Target Healthcare REIT PLC Announces Appointment of Amanda Thompsell as an Independent Non-Executive Director

Target Healthcare REIT PLC (LSE:THRL) acquired Portfolio of 18 operational modern care homes in Weymouth.

Full year 2021 earnings released: EPS UK£0.092 (vs UK£0.072 in FY 2020)

Target Healthcare REIT PLC has completed a Follow-on Equity Offering in the amount of £125 million.

Price target decreased to UK£1.30

Target Healthcare REIT PLC (LSE:THRL) acquired Luxury Care Home in Scotland and a Development site in Buckinghamshire for £33 million.

Upcoming dividend of UK£0.017 per share

Target Healthcare REIT PLC Declares Third Interim Dividend for the Year Ending 30 June 2021, Payable on 28 May 2021

First half 2021 earnings released: EPS UK£0.035 (vs UK£0.039 in 1H 2020)

What Type Of Shareholders Own The Most Number of Target Healthcare REIT PLC (LON:THRL) Shares?

Price target lowered to UK£1.30

New 90-day low: UK£1.11

Target Healthcare REIT PLC has completed a Follow-on Equity Offering in the amount of £60 million.

Target Healthcare REIT PLC (LSE:THRL) acquired Development site in Droitwich Spa.

New 90-day high: UK£1.17

Target Healthcare REIT PLC (LON:THRL) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

New 90-day high: UK£1.15

Full year earnings released

Target Healthcare REIT PLC to Report Fiscal Year 2020 Results on Oct 06, 2020

New 90-day low: UK£1.05

PDG

Titularisation